RSV

RSV: US FDA approves Pfizer's RSV vaccine for older adults at increased risk

Wed, 2024-10-23 09:48 — mike kraft

US FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in adults aged 18 to 59 at increased risk of the disease. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about RSV: US FDA approves Pfizer's RSV vaccine for older adults at increased risk
Log in or register to post comments

Analysis: Is the world prepared for another pandemic?

Mon, 2024-10-21 10:29 — mike kraft

COVID, mpox, cholera: Is the world prepared for another pandemic? About 4.5 billion people are currently without adequate access to essential healthcare. Faras Ghani Al Jazeera

Some 4.5 billion people worldwide are currently without adequate access to essential healthcare services, according to the World Health Organization (WHO).

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Analysis: Is the world prepared for another pandemic?
Log in or register to post comments

Explainer: Vaccination side effects and what they indicate

Fri, 2024-10-18 17:40 — mike kraft

What Vaccine Side Effects Really Mean And is it bad not to have side effects after a shot? Jamie Ducharme TIME

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Explainer: Vaccination side effects and what they indicate
Log in or register to post comments

Only a quarter of US adults concerned about RSV, down from 35% in 2023 --survey

Fri, 2024-10-18 17:06 — mike kraft

Survey: Only a quarter of US adults concerned about RSV, down from 35% in 2023 The disease continues to spread in the Americas, with Ecuador and Guyana recently reporting their first cases. CIDRAP

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Only a quarter of US adults concerned about RSV, down from 35% in 2023 --survey
Log in or register to post comments

RSV vaccine is highly effective in protecting older adults against severe disease, hospitalization and death

Fri, 2024-10-18 09:50 — mike kraft

Study finds RSV vaccine highly effective in protecting older adults against severe disease, hospitalization and death A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the RSV—short for respiratory syncytial virus—vaccine. VISION Network researchers ... Regenstrief Institute Medical Xpress

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

RSV: Researchers pinpoint markers of more severe cases among children

Tue, 2024-10-15 09:55 — mike kraft

Inside RSV: Researchers pinpoint markers of more severe cases Respiratory syncytial virus (RSV) remains the top cause of hospitalization among young children, leading to respiratory issues like bronchiolitis and pneumonia. However, the reasons why some children ... Brigham and Women’s Hospital Medical Xpress

Respiratory syncytial virus (RSV) remains the top cause of hospitalization among young children, leading to respiratory issues like bronchiolitis and pneumonia. However, the reasons why some children experience only mild symptoms while others suffer from severe disease are not well understood.

Country / Region Tags:

General Topic Tags: